arcadia

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE801.401.55 (+0.19 %)
PREV CLOSE ( ) 799.85
OPEN PRICE ( ) 799.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5957
TODAY'S LOW / HIGH ( )797.10 822.95
52 WK LOW / HIGH ( )671.25 1080
NSE802.700.1 (+0.01 %)
PREV CLOSE( ) 802.60
OPEN PRICE ( ) 809.95
BID PRICE (QTY) 802.70 (25)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 133107
TODAY'S LOW / HIGH( ) 797.80 820.00
52 WK LOW / HIGH ( )671.1 1090
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Andhra Pradesh-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX
NEWS
10Apr Natco Pharma submits shareholding patt
Natco Pharma has submitted the Shareholding Pattern for the Period Ended..
05Apr Adani Enterprises, Dilip Buildcon and
Adani Enterprises has received a letter of award (LoA) for a new Hybrid..
05Apr Natco Pharma launches generic version
Natco Pharma is the first company in India to launch a generic version o..
05Apr Natco Pharma gains on launching generi
Natco Pharma is currently trading at Rs. 782.05, up by 14.35 points or 1..
01Mar Natco Pharma files ANDA for Sofosbuvir
Natco Pharma has filed an Abbreviated New Drug Application (ANDA) for So..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit21734948
Gross Profit 2763 6341
Operating Profit 29757052
Net Sales 540320028
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 2225.65 (3.40%)
M.Cap ( in Cr)9836.22
Glaxosmithkline Phar (BSE)
 2432.90 (2.30%)
M.Cap ( in Cr)20074.19
Wockhardt (BSE)
 797.35 (4.52%)
M.Cap ( in Cr)8422.85
Abbott India (BSE)
 6185.00 (0.36%)
M.Cap ( in Cr)13180.09
Divis Lab (BSE)
 1193.85 (0.80%)
M.Cap ( in Cr)31386.35
Shareholding Pattern
PROMOTERS 48.38%
NON-INSTITUTION 21.35%
MUTUAL FUNDS/UTI 5.67%
FI/BANKS/INSURANCE 0.4%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM